Amos CI - Search Results

1

Cytochrome P450 2E1 DraI polymorphisms in lung cancer in minority populations.

Wu X, Amos CI, Kemp BL, Shi H, Jiang H, Wan Y, Spitz MR. Wu X, et al. Among authors: amos ci. Cancer Epidemiol Biomarkers Prev. 1998 Jan;7(1):13-8. Cancer Epidemiol Biomarkers Prev. 1998. PMID: 9456237

2

Host factors in lung cancer risk: a review of interdisciplinary studies.

Amos CI, Caporaso NE, Weston A. Amos CI, et al. Cancer Epidemiol Biomarkers Prev. 1992 Sep-Oct;1(6):505-13. Cancer Epidemiol Biomarkers Prev. 1992. PMID: 1302563 Review.

3

A case-control study of nonrandom distribution of bleomycin-induced chromatid breaks in lymphocytes of lung cancer cases.

Wu X, Hsu TC, Annegers JF, Amos CI, Fueger JJ, Spitz MR. Wu X, et al. Among authors: amos ci. Cancer Res. 1995 Feb 1;55(3):557-61. Cancer Res. 1995. PMID: 7530597

4

Mutagen sensitivity as a biological marker of lung cancer risk in African Americans.

Spitz MR, Hsu TC, Wu X, Fueger JJ, Amos CI, Roth JA. Spitz MR, et al. Among authors: amos ci. Cancer Epidemiol Biomarkers Prev. 1995 Mar;4(2):99-103. Cancer Epidemiol Biomarkers Prev. 1995. PMID: 7537995

5

Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype.

Jin X, Wu X, Roth JA, Amos CI, King TM, Branch C, Honn SE, Spitz MR. Jin X, et al. Among authors: amos ci. Carcinogenesis. 1995 Sep;16(9):2205-8. doi: 10.1093/carcin/16.9.2205. Carcinogenesis. 1995. PMID: 7554076

6

Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract.

Spitz MR, Hoque A, Trizna Z, Schantz SP, Amos CI, King TM, Bondy ML, Hong WK, Hsu TC. Spitz MR, et al. Among authors: amos ci. J Natl Cancer Inst. 1994 Nov 16;86(22):1681-4. doi: 10.1093/jnci/86.22.1681. J Natl Cancer Inst. 1994. PMID: 7966395

7

A clinical trial to evaluate the effect of vitamin C supplementation on in vitro mutagen sensitivity. The University of Texas M. D. Anderson Clinical Community Oncology Program Network.

King TM, Trizna Z, Wu X, Amos CI, Fueger RH, Fueger JJ, Fritsche HA, Hsu TC, Winn R, Spitz MR. King TM, et al. Among authors: amos ci. Cancer Epidemiol Biomarkers Prev. 1997 Jul;6(7):537-42. Cancer Epidemiol Biomarkers Prev. 1997. PMID: 9232342 Clinical Trial.

8

Estimating the strength of genetic effects: a comparison of maximum likelihood and transmission disequilibrium methods in the study of ankylosing spondylitis.

Amos CI, Wan Y, Siminovitch KA, Rubin LA. Amos CI, et al. Hum Immunol. 1997 Sep 15;57(1):44-50. doi: 10.1016/s0198-8859(97)00179-1. Hum Immunol. 1997. PMID: 9438194

9

Deletion in poly(ADP-ribose)polymerase pseudogene and lung cancer risk.

Wu X, Hsu TC, Cao S, Lee JJ, Amos CI, Spitz MR. Wu X, et al. Among authors: amos ci. Carcinogenesis. 1998 Jan;19(1):93-8. doi: 10.1093/carcin/19.1.93. Carcinogenesis. 1998. PMID: 9472699

10

Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients.

Spitz MR, Shi H, Yang F, Hudmon KS, Jiang H, Chamberlain RM, Amos CI, Wan Y, Cinciripini P, Hong WK, Wu X. Spitz MR, et al. Among authors: amos ci. J Natl Cancer Inst. 1998 Mar 4;90(5):358-63. doi: 10.1093/jnci/90.5.358. J Natl Cancer Inst. 1998. PMID: 9498485

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

864 results

Search Page

Filters